391
Views
10
CrossRef citations to date
0
Altmetric
Reviews

Human amniotic-fluid-derived stem cells: a unique source for regenerative medicine

, PhD, , MSc PhD, , MSc PhD, , MSc PhD, , MD PhD, , MD PhD, , MD PhD & , MD PhD show all
Pages 831-839 | Published online: 22 Mar 2014
 

Abstract

Introduction: The first application of tissue engineering was based on the use of differentiated cells from the adult organism, which was associated with an invasiveness and high risk of diseased cells' transplantation. Over the years, the range of available cell populations for tissue engineering has widened.

Areas covered: We review the comprehensive information concerning the characteristic features of amniotic-fluid-derived stem cells (AFSCs). We also review the potential applications of these cells in clinical practice.

Expert opinion: AFSCs hold promise for the future treatment of many incurable diseases. However, such cell-based therapies have some limitations, and there are questions relating to the use of stem cells, which should be carefully analyzed before translation of these cells into clinical practice.

Acknowledgement

A Bajek and J Olkowska equally contributed to this work.

Notes

This box summarizes key points contained in the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.